Novartis Ireland Limited
Lobbying activity
The following activities occurred for this specific Subject Matter Area.
Informal communication (1)
Conversation with Dept of Health officials about the value of innovation at the launch of report by National Clinical Trials Oversight Group (NCTOG), Iveagh House on 21st November. Minister for Health launched the report on the night.
Meeting (1)
Meeting with Deputy Albert Dolan on the 23rd September to discuss Life Science Strategy, National Cardiovascular Strategy and fast and fair access to innovation.
Event / Reception (1)
Attended an Institute of International and European Affairs on the 18th September and made a comment from the floor about Life Science Strategy and the importance of faster access to innovative treatments.
Event / Reception (1)
Engaged with Irish Ambassador to the UK at IIEA breakfast meeting.
Event / Reception (1)
British Irish Chamber Conference and dinner. Made a comment from the floor in plenary session relating to competitiveness, fast & fair access to innovation and the importance of a Life Sciences Strategy for Ireland.
Event / Reception (1)
Dublin Chamber of Conference Dinner and had an informal conversation with the Tanaiste and some of his team on the Life Sciences Strategy and valuing innovation.
Designated public officials lobbied
The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.